Latest in News & Research

Topical Terbinafine Effective for Distal, Lateral Subungual Onychomycosis

Mycological cure rate was 69.9 percent; complete cure seen for 4.5 percent, with few adverse events

By Dermsquared Editorial Team | | June 23, 2021

Interval Between Biopsy, SLNB Does Not Affect Melanoma Survival

No difference seen in melanoma-specific survival, disease-free survival, overall survival for early versus late interval

By Dermsquared Editorial Team | | June 23, 2021

Rash, Itch After COVID Vaccine Rare & Quickly Resolves

Rashes, itchiness and other skin problems can develop after people receive COVID-19 vaccines, but such problems are rare and go away quickly, new research...

By Robert Preidt (HealthDay News) | | June 23, 2021

Medicaid Enrollment Reaches Record High During Pandemic

Surge in enrollment during pandemic means that a quarter of the U.S. population is now covered by the public program

By Physician's Briefing Staff | | June 22, 2021

Poll: Many 'High-Risk' Americans Unconcerned About Skin Cancer

AAD survey revealed that 49 percent of respondents were more worried about avoiding sunburn than preventing skin cancer

By Physician’s Briefing Staff | | June 22, 2021

Risk Factors for PHACE Syndrome ID'd in Infantile Hemangiomas

Surface area of 25 cm

By Physician’s Briefing Staff | | June 17, 2021

Animal Study Offers Hope for a Better Herpes Treatment

THURSDAY, June 17, 2021 (HealthDay News) -- Aiming to deliver a one-two punch to the herpes virus, animal research on an experimental drug found...

By Alan Mozes (HealthDay News) | | June 17, 2021

Skin Rashes May Indicate Positive Test for SARS-CoV-2

17 percent of individuals report skin rashes as first presentation and 21 percent report rashes as only clinical sign of COVID-19

By Dermsquared Editorial Team | | June 16, 2021

Risk for Some Adverse Pregnancy Outcomes Up With Hidradenitis Suppurativa

In fully adjusted model, women with hidradenitis suppurativa have increased odds of spontaneous abortion, GDM, C-section

By Dermsquared Editorial Team | | June 16, 2021

Higher BMI Linked to Increased Risk for Developing Psoriasis

Hazard ratio increased for overweight, obese class 1, obese class 2/3 compared with those with BMI <25.0 kg/m

By Physician's Briefing Staff | | June 16, 2021

FDA Approves StrataGraft for Deep Partial-Thickness Thermal Burns

Data show StrataGraft helps reduce the amount of healthy skin needed for grafting

By Physician’s Briefing Staff | | June 16, 2021

Are Women Absorbing Toxins From Their Makeup?

By Physician’s Briefing Staff

By Dennis Thompson (HealthDay News) | | June 15, 2021

Third Dose of COVID Vaccine Boosts Protection in Transplant Recipients

By Physician’s Briefing Staff

By Robert Preidt (HealthDay News) | | June 15, 2021

Narrowband UVB, Topical Steroid Combo Superior for Vitiligo

Combination treatment superior to topical corticosteroids alone, but target patch treatment success only 27 percent with combination

By Dermsquared Editorial Team | | June 09, 2021

SARS-CoV-2 Not Detected in Surgical Electrocautery Plume

No virus was recovered from electrocautery performed using cell titer glow measurement for replicating virus

By Dermsquared Editorial Team | | June 09, 2021

Second-Opinion Strategy Analyzed for Cutaneous Melanocytic Lesions

Decision-analytic model shows selective second-opinion strategy could increase diagnostic accuracy, decrease population-level costs

By Physician’s Briefing Staff | | June 09, 2021

Barriers to Physician Skin Exam ID'd for Young Melanoma Survivors

Barriers to health care access linked to increased odds of suboptimal physician skin examination adherence

By Physician’s Briefing Staff | | June 09, 2021

Gap Between Mortality in Rural and Urban Areas Has Increased

Difference increased in age-adjusted mortality rates between large metropolitan areas, rural areas from 1999 to 2019

By Physician’s Briefing Staff | | June 08, 2021

Drop in Kawasaki Disease Seen During the COVID-19 Pandemic

Incidence decreased sharply after implementation of nonpharmaceutical interventions, such as mask wearing; seasonal pattern absent

By Physician’s Briefing Staff | | June 08, 2021

Real-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVID-19

Symptomatic and asymptomatic infection reduced by 81 percent after partial vaccination and by 91 percent after full vaccination

By Physician’s Briefing Staff | | June 08, 2021

Dermatologists Receptive to AI, AuI for Diagnosis of Skin Lesions

Implementation challenges include disruption of the human physician-patient relationship, threats to accuracy

By Dermsquared Editorial Team | | June 02, 2021

Review Links Topical Calcineurin Inhibitors With Lymphoma Risk

No association seen between topical calcineurin inhibitor use and cancer overall compared with nonactive comparators

By Dermsquared Editorial Team | | June 02, 2021

NIH Starts Trial Assessing 'Mix & Match' COVID Vaccine Approach

Moderna plus Pfizer? J&J plus Moderna? There's a new clinical trial underway to assess the safety and effectiveness of mixing different types of booster...

By Physician’s Briefing Staff | | June 02, 2021

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026